For the Quarter Ending March 2026
Cefaclor Prices in North America
- In USA, the Cefaclor Price Index rose by 4.117% quarter-over-quarter, driven by higher freight and constrained supply.
- The average Cefaclor price for the quarter was approximately USD 227947.00/MT.
- Cefaclor Spot Price remained range bound as steady Asian export volumes and logistics kept landed costs stable.
- Cefaclor Price Forecast indicates modest upward bias due to anticipated cautious restocking and sustained freight pressure.
- Cefaclor Production Cost Trend reflects higher logistics and intermediary retesting costs, modestly supporting CFR levels.
- Cefaclor Demand Outlook stays neutral to firm with stable prescriptions and hospital tenders maintaining routine procurement.
- Cefaclor Price Index showed sequential strengthening reflecting mid-quarter freight spikes and tighter compliant spot availability.
- Import inventories at Los Angeles terminals remained steady, but selective quality audits tightened spot availability.
Why did the price of Cefaclor change in March 2026 in North America?
- A freight spike in March significantly raised landed CFR costs for import-dependent US supply chains.
- Selective quality re-testing of 7-ACA intermediates constrained compliant export lots, reducing available spot volumes.
- Importers accelerated purchases ahead of summer, drawing on tight compliant supply and increasing near-term demand.
Cefaclor Prices in APAC
- In China, the Cefaclor Price Index rose by 4.11% quarter-over-quarter, reflecting firmer export bookings overall.
- The average Cefaclor price for the quarter was approximately USD 227830/MT, FOB Shanghai basis reported.
- Reduced warehouse inventories pushed the Cefaclor Spot Price higher, supporting the Cefaclor Price Index upward.
- Moderate regulatory compliance spending shifted the Cefaclor Production Cost Trend modestly higher, pressuring exporter margins.
- Positive guideline changes improved the Cefaclor Demand Outlook, prompting forward purchases from Latin American and Asian buyers.
- Near-term Cefaclor Price Forecast indicates modest gains as exporters test marginal price improvements amid steady demand.
- Port congestion remained minimal, but tighter coastal inventories supported the Cefaclor Price Index resilience during.
- Manufacturing rhythms stayed stable; coal-fired cogeneration maintained conversion economics, cushioning the Cefaclor Spot Price effectively.
Why did the price of Cefaclor change in March 2026 in APAC?
- Tighter export bookings increased outbound demand, reducing available coastal inventories and elevating FOB offers promptly.
- Higher compliance spending raised conversion costs at Jiangsu plants, reflecting a notable production cost pressure.
- Minor vessel queueing and spring cargo volumes lengthened schedules slightly, supporting sellers' firmer pricing stance.
Cefaclor Prices in Europe
- In Germany, the Cefaclor Price Index rose by 4.13% quarter-over-quarter, reflecting tighter Asian export availability.
- The average Cefaclor price for the quarter was approximately USD 227955/MT as reported by import statistics.
- Cefaclor Spot Price firmed in March as reduced Chinese allocations tightened availability for German formulators.
- Cefaclor Price Forecast indicates firmness driven by importers restocking and constrained Asian export volumes ahead.
- Cefaclor Production Cost Trend saw upward pressure from elevated maritime insurance and euro weakness recently.
- Cefaclor Demand Outlook steady; paediatric prescriptions support offtake while reimbursement ceilings restrict pricing freedom locally.
- Cefaclor Price Index volatility increased as Chinese environmental inspections curtailed shipments and tightened European availability.
- Importers adjusted procurement cadence, drawing down stocks selectively restocking, aligning with the Cefaclor Price Forecast.
Why did the price of Cefaclor change in March 2026 in Europe?
- Chinese environmental inspections cut exports in March, prompting competition for Indian lots among European buyers.
- Maritime insurance hikes and longer routing raised landed costs, exerting upward pressure on German CFR.
- Steady paediatric prescriptions sustained offtake while reimbursement ceilings constrained formulators' ability to pass through costs.
For the Quarter Ending December 2025
Cefaclor Prices in APAC
- In China, the Cefaclor Price Index rose by 1.39% quarter-over-quarter, supported by export procurement patterns.
- The average Cefaclor price for the quarter was approximately USD 218833.33/MT, based on export averages.
- Cefaclor Spot Price remained firm as contracted volumes constrained prompt availability despite balanced export-oriented inventories.
- Cefaclor Production Cost Trend stayed elevated due to coal-linked steam tariffs and steady utility charges.
- Cefaclor Demand Outlook remains constructive driven by predictable winter offtake and targeted replenishment from importers.
- Cefaclor Price Forecast indicates narrow near-term banding with upward risk if environmental inspections trigger plant outages.
- Cefaclor Price Index movement reflected steady exporter confidence, constrained spot availability, and sustained procurement momentum.
- Operating rates remained high while Shanghai port scheduling eased congestion, maintaining reliable outbound flows and exports.
Why did the price of Cefaclor change in December 2025 in APAC?
- Sustained high operating rates and limited medium-scale reactor idlings tightened prompt availability, supporting marginal price increase.
- Elevated coal-linked steam and utility tariffs maintained conversion costs, preventing downward pressure on producer margins.
- Consistent export procurement, importer replenishment, and manageable Shanghai port scheduling balanced supply-demand, limiting marginal volatility.
Cefaclor Prices in Europe
- In Germany, the Cefaclor Price Index rose by 1.38% quarter-over-quarter, reflecting import-cost increases from Asia.
- The average Cefaclor price for the quarter was approximately USD 218918.33/MT across CFR Hamburg deliveries.
- Cefaclor Spot Price strengthened as Germany's Price Index absorbed FOB increases from China and India
- Cefaclor Price Forecast signals firmness, supported by Asian supply constraints and Cefaclor Production Cost Trend
- Cefaclor Demand Outlook remains steady, with formulators making routine purchases supporting the Germany Price Index
- Inventory levels at Hamburg remained moderate-to-low, limiting upside and keeping the Cefaclor Price Index measured.
- Port congestion encouraged adherence to schedules, reducing spot availability and tightening the Cefaclor Spot Price
- Export demand from Asia plus year-end environmental audits constrained flows, reinforcing the Cefaclor Price Forecast
Why did the price of Cefaclor change in December 2025 in Europe?
- Asian supply tightened due to intensified inspections and year-end production scheduling reducing available export volumes
- Freight surcharges remained stable, so landed costs rose from higher FOB levels and constrained availability
- Domestic demand stayed steady, limiting offtake; supply-side constraints transmitted directly into the German Price Index
Cefaclor Prices in North America
- In USA, the Cefaclor Price Index rose by 1.39% quarter-over-quarter, reflecting procurement and steady demand.
- The average Cefaclor price for the quarter was approximately USD 218933.33/MT, reflecting import-weighted landed costs.
- Cefaclor Spot Price remained muted as West Coast inventories and planned imports maintained balanced availability.
- Cefaclor Price Forecast suggests a narrow trading range supported by steady imports and easing freight.
- Cefaclor Production Cost Trend showed upward pressure from higher 7-ACA costs passed through Asian suppliers.
- Cefaclor Demand Outlook remains steady with paediatric prescriptions and formulators replenishing moderate inventories for production.
- Cefaclor Price Index stability reflected disciplined purchasing, shipments, and absence of regulatory disruptions this quarter.
- Inventory cushioning and late freight relief limited volatility, keeping Cefaclor supply sufficient for routine demand.
Why did the price of Cefaclor change in December 2025 in North America?
- Consistent Chinese and Indian exports maintained supply, preventing significant December upward pressure on Cefaclor prices.
- Refrigerated freight rates fell late, easing logistics costs, but most December bookings completed before decline.
- Stable seasonal paediatric prescriptions and formulators' planned replenishment sustained demand, keeping market balanced and predictable.
For the Quarter Ending September 2025
North America
- In USA, the Cefaclor Price Index fell by 2.40% quarter-over-quarter, reflecting mild post-restocking market softness.
- The average Cefaclor price for the quarter was approximately USD 215931.00/MT, reported by trade handlers.
- Cefaclor Spot Price softened as frontloaded imports and normalized logistics reduced urgent spot purchasing across channels.
- Cefaclor Price Forecast indicates modest volatility with seasonal restocking and tariff uncertainty affecting near-term trajectories.
- Cefaclor Production Cost Trend showed upward pressure from inflationary logistics and handling, partially offset by freight stabilization.
- Cefaclor Demand Outlook remains cautious as buyers pause after aggressive pre-tariff purchasing, moderating short-term off-take.
- Cefaclor Price Index movements reflected inventory normalization and selective distributor discounts to clear aging stocks efficiently.
- Cefaclor Spot Price and inventory balances influenced export demand patterns and distributor replenishment timing across the coast.
Why did the price of Cefaclor change in September 2025 in North America?
- Import volumes decreased after July frontloading, releasing supply pressure and easing upward price momentum.
- Port congestion eased and logistics costs declined, reducing landed costs and lowering price pressure.
- Buyers delayed purchases amid tariff uncertainty, diminishing short-term demand and prompting supplier price concessions.
APAC
- In China, the Cefaclor Price Index fell by 2.382% quarter-over-quarter, reflecting weaker export demand and logistics.
- The average Cefaclor price for the quarter was approximately USD 215833.33/MT reflecting shipment patterns and inventories.
- Cefaclor Spot Price softened in August as front-loaded exports reduced buying and elevated onshore inventories.
- Cefaclor Price Forecast suggests volatility; the Price Index signals slight recovery as shipments normalize Q4.
- Cefaclor Production Cost Trend showed upward pressure from freight and weather disruptions, increasing unit costs.
- Cefaclor Demand Outlook remains subdued post-frontloading; distributors pause purchases, though year-end restocking could revive activity later.
- Cefaclor Price Index movements reflected balanced supply demand; port delays constrained flows while inventories stayed elevated.
- Major Chinese producers kept calibrated output, limiting spot availability while avoiding overproduction amid tariff uncertainty.
Why did the price of Cefaclor change in September 2025 in APAC?
- Export demand remained muted after front-loaded shipments, reducing new orders and softening spot market pricing.
- Freight and PSS removal lowered export costs, enabling suppliers to ease offers and reduce the Price Index.
- Port disruptions and delays constrained flows, prompting cautious purchasing and limiting upward pressure on prices.
Europe
- In Germany, the Cefaclor Price Index fell by 2.38% quarter-over-quarter in Q3 2025, port congestion.
- The average Cefaclor price for the quarter was approximately USD 215937.33/MT, reported by CFR Hamburg sources.
- Shipping delays tightened supply and pushed the Cefaclor Spot Price higher, reflecting logistics costs and uncertainty.
- Forward curves and market commentary inform the Cefaclor Price Forecast suggesting volatility through autumn months.
- Elevated freight and rerouting increased expenses, tightening the Cefaclor Production Cost Trend over the quarter.
- Downstream purchasing patterns shaped the Cefaclor Demand Outlook with cautious restocking and reduced spot buying evident.
- Inventories at distributors remained adequate, moderating the Cefaclor Price Index despite localized shortages and shipment delays.
- Major importer operations stabilized, limiting upside; near term interventions likely to anchor the Cefaclor Price Index.
Why did the price of Cefaclor change in September 2025 in Europe?
- Severe port congestion and Rhine low water levels delayed imports, compressing supply and raising costs.
- Higher freight surcharges and rerouting increased procurement expenditure, squeezing margins and influencing payable prices overall.
- Cautious buyer behavior and existing stocks reduced spot demand, slightly easing upward pressure on prices.
For the Quarter Ending June 2025
North America
- The Cefaclor Price Index in the USA showed marginal growth across Q2, rising from USD 220,900/MT in April to USD 221,120/MT in May, and USD 221,687/MT in June, reflecting a cumulative quarterly increase of 0.72%.
- In April, the product spot price edged higher as a response to the newly imposed 145% tariff on Chinese goods, triggering pre-tariff stockpiling and shifting product production cost trends upward due to elevated landed costs and complex logistics.
- April's product demand outlook remained steady, bolstered by slowing inflation (CPI at 2.3%) and improved consumer confidence, which encouraged forward procurement strategies across the pharmaceutical supply chain.
- In May, Cefaclor prices experienced a 0.10% Price Index rise due to continued frontloading driven by a 90-day tariff suspension, with heightened shipping activity and the onset of Peak Season Surcharges (PSS) impacting overall cost structure.
- Port congestion and extended container turnaround times in May added subtle upward pressure to product spot prices, while the threat of June’s General Rate Increase (GRI) led to moderate stockpiling.
- May's product demand outlook was reinforced by positive business sentiment amid inflation recovery, motivating distributors to build inventory in anticipation of future logistics challenges.
- In June, the Price Index increased another 0.26%, primarily shaped by proactive importer behavior amid persistent trade uncertainty and inflation-linked supply chain costs.
- June also saw advanced shipments of Q3 and Q4 inventories, subtly tightening supply and reinforcing an upward trajectory in product production cost trend.
- Domestic demand for Cefaclor stayed consistent in June, but a shift toward anticipatory procurement amid inflation and tariff speculation maintained modest pressure on availability and pricing.
- For July 2025, the Cefaclor price forecast points to a slight decrease, as post-frontloading restocks ease, demand softens, and suppliers reduce prices to remain competitive—indicating a temporary dip in the product spot price and a more subdued product demand outlook.
APAC
- The Price Index for Cefaclor in China rose modestly across Q2 2025, moving from USD 220,800/MT in April to USD 221,500/MT in June, reflecting a cumulative quarterly increase of 0.68%.
- In April, the Cefaclor spot price saw a moderate uptick as domestic and export buyers ramped up inventory replenishment, reacting to future supply stability concerns. This shift supported a bullish Product price forecast.
- Despite a slowing manufacturing PMI of 49.0, supply conditions remained tight due to depleted March inventories, pushing the Price Index up as lean stocks and procurement urgency drove short-term gains.
- Product demand outlook strengthened in April, led by consistent pharmaceutical consumption and revived exports to Asia and Europe.
- In May, the Cefaclor Price Index increased only slightly by 0.09%, as production normalized after the Labour Day pause and supply remained robust.
- Export logistics became more complex due to a 27% hike in container freight rates, though Cefaclor sellers avoided significant price shifts due to steady product flow and managed shipping capacity.
- The Product spot price remained largely stable in May as buyers showed restrained yet consistent ordering behavior, particularly from the U.S., Europe, and Asia.
- In June, the Price Index rose again by 0.23%, driven by frontloaded export orders following a temporary U.S. tariff suspension. Shipping costs increased further, affecting the product production cost trend.
- Chinese producers scaled up slightly to meet export demand but remained cautious with capacity, wary of the post-suspension volatility expected in Q3.
- In July 2025, Cefaclor prices are likely to decrease slightly as demand softens post-advanced ordering, while supply remains cautiously stable amid subdued domestic expansion.
Europe
- The Cefaclor Price Index in Germany showed a steady uptrend in Q2, moving from USD 220,887/MT in April to USD 221,610/MT in June, marking a quarterly gain of approximately 0.69%.
- In April, the product spot price rose moderately due to logistics disruptions from Easter holidays and port congestion at Hamburg and Rotterdam.
- Trade redirection from the U.S. to Europe amid new tariffs created a temporary supply strain, affecting product demand outlook and increasing warehouse activity in Germany.
- The Price Index increased by 0.36% in April, supported by firmer downstream demand and precautionary restocking amid tighter delivery timelines.
- May saw a marginal Price Index uptick of 0.09%, with stable product spot price movement as suppliers managed steady inventory flows despite persistent freight congestion.
- Importers in May maintained regular procurement patterns, avoiding stockpiling while responding cautiously to shipping constraints, keeping the product demand outlook balanced.
- In June, further port congestion and Rhine River low water levels caused extended lead times, prompting early restocking and a Price Index increase of 0.24%.
- Despite inflation cooling to 2%, delayed shipments from Asia prompted cautious optimism and mild price hikes to ensure timely deliveries.
- The product price forecast for July 2025 indicates a modest decrease, as demand softens post-restocking and supply disruptions ease.
- Stabilization in logistics and improved freight schedules are likely to reduce procurement costs, reflecting a downward product production cost trend.
